MARKET

GOVX

GOVX

Geovax Labs Inc
NASDAQ
1.293
-0.027
-2.02%
Opening 09:40 06/23 EDT
OPEN
1.270
PREV CLOSE
1.320
HIGH
1.310
LOW
1.260
VOLUME
58.50K
TURNOVER
--
52 WEEK HIGH
24.50
52 WEEK LOW
0.9631
MARKET CAP
6.74M
P/E (TTM)
-0.0596
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GOVX last week (0615-0619)?
Weekly Report · 1d ago
GeoVax Shareholders Back Board, Auditor and Warrant Issuances
TipRanks · 5d ago
GeoVax Labs shareholders approve Wipfli as independent auditor for 2026
PUBT · 5d ago
Weekly Report: what happened at GOVX last week (0608-0612)?
Weekly Report · 06/15 09:39
BARDA supporting development of Bundibugyo ebolavirus vaccine candidates
TipRanks · 06/12 17:05
Weekly Report: what happened at GOVX last week (0601-0605)?
Weekly Report · 06/08 09:37
U.S. State Dept Announces Nearly $38M In Additional Funding Toward The Department's Ongoing Ebola Response Efforts
Benzinga · 06/05 18:24
WHO reports drop in suspected Ebola cases in Africa, France 24 says
TipRanks · 06/02 19:45
More
About GOVX
GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel vaccines against infectious diseases and therapies for solid tumor cancers. Its lead clinical program is GEO-CM04S1, a COVID-19 vaccine, which is in three phase II clinical trials, being evaluated as a primary vaccine for immunocompromised patients, such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient; a booster vaccine in patients with chronic lymphocytic leukemia (CLL); and a COVID-19 booster among healthy patients who previously received the mRNA vaccines. In oncology, the lead clinical program is evaluating a novel oncolytic solid tumor gene-directed therapy, Gedeptin, having completed a multicenter Phase I/II clinical trial for advanced head and neck cancers. It is developing GEO-MVA, a vaccine targeting Mpox and smallpox. Its other product candidates include GEO-EM01-Z, GEO-EM01-S, GEO-MM01, GEO-ZM02 and others.

Webull offers Geovax Labs Inc stock information, including NASDAQ: GOVX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GOVX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GOVX stock methods without spending real money on the virtual paper trading platform.